A New Dawn for Sight: How Robots Are Poised to End a Global Vision Crisis

Charlotte AndersonJun 24, 2025
A dramatic, high-contrast, close-up shot of the ORYOM™ robotic arm's delicate surgical instrument poised with extreme precision over a model of a human eye. The lighting is focused and clinical, highlighting the advanced technology and futuristic design, conveying a sense of sterile power and unparalleled accuracy.
  • Colossal Backing: ForSight Robotics has secured a massive $125 million in new funding to advance its groundbreaking robotic eye surgery platform, bringing its total capital to $195 million1, 2, 5.
  • Revolutionary Technology: The ORYOM™ platform is the world's first robotic system designed for cataract, glaucoma, and retinal surgeries, leveraging AI and micromechanics for superhuman precision1, 5.
  • Addressing a Global Need: This innovation directly confronts a critical global shortage of ophthalmologists, aiming to provide sight-saving procedures to millions who currently lack access5.

A silent crisis is casting a shadow over global health: over 600 million people suffer from cataracts, yet only a fraction ever receive the surgery that could restore their sight5. As the demand for eye care explodes, the number of specialist surgeons is projected to decline, threatening to leave millions in darkness.

But a new dawn is breaking. From Israel, ForSight Robotics is emerging as a beacon of hope with its revolutionary ORYOM™ platform. This is not just another surgical tool; it is a microsurgical marvel. Named for the Hebrew word for “daylight,” ORYOM™ combines artificial intelligence, advanced computer vision, and impossibly steady robotic hands to perform the most delicate eye operations with unprecedented precision.

This world-changing potential has attracted a colossal $125 million in Series B funding, led by Eclipse. The investment round includes the "father of surgical robotics" himself, Dr. Fred Moll, founder of Intuitive Surgical and creator of the da Vinci system1, 2. This immense vote of confidence signals a tectonic shift in medicine, with ophthalmology as the next frontier in the robotics revolution.

Having already achieved key safety and quality certifications and completed hundreds of successful procedures on eye models, ForSight Robotics is now preparing for first-in-human clinical trials1, 4. This is more than an advancement in technology; it's a mission to democratize vision and bring sight to the world.


References

  1. community.hlth.com
  2. www.businesswire.com
  3. www.biospace.com
  4. www.businesswire.com
  5. www.fiercebiotech.com
  6. www.massdevice.com
  7. www.forsightrobotics.com
  8. www.forsightrobotics.com

Stay Updated!

Get the latest biotech and pharma news delivered to your inbox.